KR950700402A - 세포용해성 t 세포전구체를 결정하는 방법(method for determining cytolytic t cell precursors) - Google Patents
세포용해성 t 세포전구체를 결정하는 방법(method for determining cytolytic t cell precursors)Info
- Publication number
- KR950700402A KR950700402A KR1019940702508A KR19940702508A KR950700402A KR 950700402 A KR950700402 A KR 950700402A KR 1019940702508 A KR1019940702508 A KR 1019940702508A KR 19940702508 A KR19940702508 A KR 19940702508A KR 950700402 A KR950700402 A KR 950700402A
- Authority
- KR
- South Korea
- Prior art keywords
- cells
- tumor
- antigen
- cytolytic
- subject
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82393392A | 1992-01-21 | 1992-01-21 | |
US07/823.933 | 1992-01-21 | ||
PCT/US1993/000083 WO1993014189A1 (en) | 1992-01-21 | 1993-01-07 | Method for determining cytolytic t cell precursors |
Publications (1)
Publication Number | Publication Date |
---|---|
KR950700402A true KR950700402A (ko) | 1995-01-16 |
Family
ID=25240169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019940702508A KR950700402A (ko) | 1992-01-21 | 1993-01-07 | 세포용해성 t 세포전구체를 결정하는 방법(method for determining cytolytic t cell precursors) |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0624189A4 (no) |
JP (1) | JPH07503134A (no) |
KR (1) | KR950700402A (no) |
AU (1) | AU3435293A (no) |
CA (1) | CA2128424A1 (no) |
FI (1) | FI943422A0 (no) |
NO (1) | NO942660L (no) |
WO (1) | WO1993014189A1 (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100261856B1 (ko) * | 1991-05-23 | 2000-07-15 | 에드워드 에이. 맥더모 2세, 로이드 제이. 오울드 | 종양 거부 항원 전구체, 종양 거부 항원 및 그 용도 |
US6352826B1 (en) | 1991-11-25 | 2002-03-05 | Yoreh Biotechnologies, Ltd. | Method and kit for the detection of retroviral specific antibodies in seronegative individuals |
US6280962B1 (en) | 1991-11-25 | 2001-08-28 | Yoreh Biotechnologies Ltd. | Whole blood/mitogen assay for the early detection of a subject with cancer and kit |
US6322989B1 (en) | 1991-11-25 | 2001-11-27 | Yoreh Biotechnologies, Ltd. | Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit |
US5874560A (en) * | 1994-04-22 | 1999-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Melanoma antigens and their use in diagnostic and therapeutic methods |
CA2188432C (en) | 1994-04-22 | 2011-02-01 | Yutaka Kawakami | Melanoma antigens |
US5843648A (en) * | 1995-01-10 | 1998-12-01 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods |
US6951917B1 (en) | 1995-09-26 | 2005-10-04 | The United States Of America As Represented By The Department Of Health And Human Services | MHC-class II restricted melanoma antigens and their use in therapeutic methods |
US7501501B2 (en) | 1995-09-26 | 2009-03-10 | The United States Of America As Represented By The Secretary Department Of Health And Human Services | MHC-Class II restricted melanoma antigens and their use in therapeutic methods |
AU1394497A (en) * | 1996-01-17 | 1997-08-11 | Imperial College Innovations Limited | Immunotherapy using cytotoxic t lymphocytes (ctl) |
US20040156861A1 (en) | 1996-07-11 | 2004-08-12 | Figdor Carl Gustav | Melanoma associated peptide analogues and vaccines against melanoma |
AU5066098A (en) * | 1996-11-22 | 1998-06-10 | Shiloov Medical Technologies Ltd. | A whole blood/mitogen assay for the early detection of a subject with cancer and kit |
-
1993
- 1993-01-07 KR KR1019940702508A patent/KR950700402A/ko not_active Application Discontinuation
- 1993-01-07 JP JP5512545A patent/JPH07503134A/ja active Pending
- 1993-01-07 EP EP93902961A patent/EP0624189A4/en not_active Withdrawn
- 1993-01-07 CA CA002128424A patent/CA2128424A1/en not_active Abandoned
- 1993-01-07 WO PCT/US1993/000083 patent/WO1993014189A1/en not_active Application Discontinuation
- 1993-01-07 AU AU34352/93A patent/AU3435293A/en not_active Abandoned
-
1994
- 1994-07-15 NO NO942660A patent/NO942660L/no unknown
- 1994-07-19 FI FI943422A patent/FI943422A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO942660D0 (no) | 1994-07-15 |
JPH07503134A (ja) | 1995-04-06 |
EP0624189A4 (en) | 1995-05-17 |
FI943422A (fi) | 1994-07-19 |
NO942660L (no) | 1994-09-16 |
EP0624189A1 (en) | 1994-11-17 |
AU3435293A (en) | 1993-08-03 |
FI943422A0 (fi) | 1994-07-19 |
WO1993014189A1 (en) | 1993-07-22 |
CA2128424A1 (en) | 1993-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR950700402A (ko) | 세포용해성 t 세포전구체를 결정하는 방법(method for determining cytolytic t cell precursors) | |
DE3476421D1 (en) | Microbiological testing apparatus | |
ES530691A0 (es) | Un procedimiento de ensayo para la deteccion de la presencia de un derivado de fibrina reticulado en un fluido corporal de un animal. | |
ATE136909T1 (de) | Igg3-antikörper mit verkürzter hinge-region und einem komplementaktivierungstest | |
Slein et al. | Partial purification and properties of two phospholipases of Bacillus cereus | |
NO932320D0 (no) | Fremgangsmaate for paavisning av en analytt i en proeve og et utstyrsett for denne | |
Lan et al. | Controversies and considerations in the diagnosis of primary cutaneous CD4+ small/medium T-cell lymphoma | |
Weber et al. | Caribbean Reef Corals Montastrea annularis and Montastrea cavernosa--Long-Term Growth Data as Determined by Skeletal X-radiography: Reef Biota | |
DE3789781D1 (de) | Antigene, Antikörper und Verfahren zur Identifizierung humaner metastatischer Tumoren und Zellinien zur Herstellung dieser Antikörper. | |
DE69123723T2 (de) | Diagnostisches verfahren und reagenz für hiv | |
ATA36892A (de) | Verfahren zur immunologischen erkennung maligner tumore und kit zur durchführung dieses verfahrens | |
Constans et al. | Relationship between Hp1S and Hp2 gene frequencies among human populations | |
Watson Jr et al. | Detection of tumor-specific antigens in an equine sarcoid cell line | |
ATA261687A (de) | Laktoferrin enthaltendes inkubationsmedium für festphasen-immunometrische verfahren und seine verwendung | |
DE69534876D1 (de) | Nematizides mittel und verfahren zur biologischen bekämpfung von nematoden | |
Kinny et al. | A new insight into Lewisian chronology | |
Zykov et al. | Non-tuberculosis mycobacteria in Africa: 3. Formamidase activity—its evaluation and practical application | |
Ahmann et al. | The reaction of three purified lectins with guinea pig lymphocytes | |
Cope | Dimorphism in a Tethyan early Jurassic Juraphyllites | |
Çavdar et al. | Effect of Human Serum Thymic Factor on Immature T Lymphocytes in Acute Leukemia and other Hematologic Malignancies | |
Heatherman | Interrelationships between biochemical properties and susceptibility to antibiotics and sulfathiazole of strains of viridans streptococci and enterococci | |
Rakestraw | Phosphate, Nitrate and Nitrite in the Sea-Water of Regions Adjacent to Cape Cod | |
Sabater et al. | A simple identification system for rapidly growing mycobacteria (a note) | |
Bruce | Mutants of the biological clock in Chlamydomonas reinhardi. | |
Petrovská et al. | The Polarographic Analysis of Seminal Fluids as a Method for the Study of Their Antigenicity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |